George W. LeMaitre - Dec 22, 2021 Form 4 Insider Report for LEMAITRE VASCULAR INC (LMAT)

Signature
/s/ Laurie A. Churchill, Attorney-in-fact
Stock symbol
LMAT
Transactions as of
Dec 22, 2021
Transactions value $
$1,236,043
Form type
4
Date filed
12/27/2021, 08:43 PM
Previous filing
Mar 28, 2022
Next filing
Mar 28, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LMAT Common Stock Options Exercise $0 +41 +0% $0.00 2.53M Dec 22, 2021 Direct F1
transaction LMAT Common Stock Tax liability -$26.7K -532 -0.02% $50.16 2.53M Dec 22, 2021 Direct F2
transaction LMAT Common Stock Options Exercise $365K +11.7K +0.46% $31.30 2.54M Dec 22, 2021 Direct F3
transaction LMAT Common Stock Options Exercise $300K +12.7K +0.5% $23.56 2.55M Dec 22, 2021 Direct F3
transaction LMAT Common Stock Options Exercise $305K +8.61K +0.34% $35.48 2.56M Dec 22, 2021 Direct F3
transaction LMAT Common Stock Options Exercise $292K +7.84K +0.31% $37.29 2.57M Dec 22, 2021 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LMAT Dividend Equivalent Rights Options Exercise $0 -41 -48.81% $0.00 43 Dec 22, 2021 Common Stock 41 Direct F4
transaction LMAT Stock Option (Right to Buy) Options Exercise $0 -11.7K -50% $0.00 11.7K Dec 22, 2021 Common Stock 11.7K $31.30 Direct F5, F6
transaction LMAT Stock Option (Right to Buy) Options Exercise $0 -12.7K -33.33% $0.00 25.5K Dec 22, 2021 Common Stock 12.7K $23.56 Direct F5, F7
transaction LMAT Stock Option (Right to Buy) Options Exercise $0 -8.61K -25% $0.00 25.8K Dec 22, 2021 Common Stock 8.61K $35.48 Direct F5, F8
transaction LMAT Stock Option (Right to Buy) Options Exercise $0 -7.84K -20% $0.00 31.3K Dec 22, 2021 Common Stock 7.84K $37.29 Direct F5, F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.
F2 These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on December 22, 2017. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934.
F3 Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.
F4 These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 22, 2017. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F5 This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, and the balance vests in equal annual installments over the remaining four years, with the final vesting occurring on the 11th month after the fourth anniversary.
F6 The expiration date of this option to the extent it is an incentive stock option is 12/22/2022, and the expiration date of this option to the extent it is a nonqualified stock option is 12/22/2024.
F7 The expiration date of this option to the extent it is an incentive stock option is 12/19/2023, and the expiration date of this option to the extent it is a nonqualified stock option is 12/19/2025.
F8 The expiration date of this option to the extent it is an incentive stock option is 12/20/2024, and the expiration date of this option to the extent it is a nonqualified stock option is 12/20/2026.
F9 The expiration date of this option to the extent it is an incentive stock option is 12/2/2025, and the expiration date of this option to the extent it is a nonqualified stock option is 12/2/2027.